Showing 1511-1520 of 1690 results for "".
- Study Evaluates Botox as Essential Tremor Treatmenthttps://practicalneurology.com/news/study-evaluates-botox-as-essential-tremor-treatment/2483937/Treatment with Botox (onabotulinumtoxinA; AbbVie, North Chicago, IL) was associated with significant improvements in functional outcomes in people with upper limb essential tremor (ET) compared with placebo in study results presented at the 2025 International Congress of Parkinson’s Disease and M
- Long-Term Data Support Ravulizumab for NMOSDhttps://practicalneurology.com/news/long-term-data-support-ravulizumab-for-nmosd/2483586/Final analysis of results from the long-term extension of the CHAMPION-NMOSD clinical trial (NCT04201262) showed that treatment with Ultomiris (ravulizumab; Alexion—AstraZeneca Rare Disease, Boston, MA) was associated with relapse prevention and stable or improved disability outcomes in adults wi
- Study Examines Effects of Chemotherapy in Individuals with Cancer and MShttps://practicalneurology.com/news/study-examines-effects-of-chemotherapy-in-individuals-with-cancer-and-ms/2483538/New findings from an analysis of data from the MSBase registry (MSBase.org) suggest that chemotherapy for cancer may be associated with a temporary protective effect against multiple sclerosis (MS) relapses, offering clinicians important real-world insights on disease-modifying therapy (DMT) mana
- Anti-CD20 Therapies Outperform Platform DMTs in Pediatric MShttps://practicalneurology.com/news/high-efficacy-anti-cd20-vs-platform-therapies-in-prepubertal-pediatric-ms/2483537/Anti-CD20 therapies were associated with superior outcomes compared with traditional platform disease-modifying treatments (DMTs) for children with prepubertal-onset multiple sclerosis (MS) according to study results presented at the 41st Congress of the European Committee for Treatment and Resea
- Paramagnetic Rim Lesions May Support Diagnosis in People with Suspected MShttps://practicalneurology.com/news/paramagnetic-rim-lesions-show-diagnostic-value-in-multiple-sclerosis-clinics/2483418/Paramagnetic rim lesions (PRLs), which are visible on susceptibility-based MRI, may serve as a useful diagnostic marker in people undergoing evaluation for multiple sclerosis (MS), according to a new study published in Neurology. The presence of PRLs was associated with increased diagnos
- GLP-1 Receptor Agonists Linked to Better Outcomes in Idiopathic Intracranial Hypertension Than Standard Therapyhttps://practicalneurology.com/news/glp-1-receptor-agonists-linked-to-better-outcomes-in-idiopathic-intracranial-hypertension-than-standard-therapy/2483417/Results from a large retrospective study published in JAMA Neurology suggest that glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy may offer benefits for patients with idiopathic intracranial hypertension (IIH). Compared with conventional therapies, GLP-1 RA use was associated
- Education May Not Prevent or Slow Cognitive Decline According to Results of a Large-Scale Longitudinal Cohort Studyhttps://practicalneurology.com/news/education-may-not-prevent-or-slow-cognitive-decline-according-to-results-of-a-large-scale-longitudinal-cohort-study/2483014/Education may have a smaller role in slowing cognitive decline and improving brain health than previously thought, according to new study results published in Nature Medicine. Educational attainment was associated with better cognitive performance in later life, higher memory test scores
- Four-Year Clarity-AD Data Show Slower Clinical Decline with Leqembi Treatmenthttps://practicalneurology.com/news/four-year-clarity-ad-data-show-slower-clinical-decline-with-leqembi-treatment/2475914/According to new 48-month data from the Clarity-AD (NCT03887455) open-label extension (OLE) study presented at the 2025 meeting of the Alzheimer’s Association International Conference (AAIC), individuals with early Alzheimer disease (AD) who received continuous treatment with Leqembi (lecanemab-i
- US POINTER Study Results: A Structured Lifestyle Intervention Improved Cognition in Older Adultshttps://practicalneurology.com/news/us-pointer-study-results-a-structured-lifestyle-intervention-improved-cognition-in-older-adults/2475903/Findings from the US POINTER clinical trial (NCT03688126) were presented at the 2025 meeting of the Alzheimer’s Association International Conference (AAIC), demonstrating significant benefits linked to lifestyle interventions for older adults at risk of cognitive decline and dementia. According t
- Intra-Arterial Tenecteplase After Successful Thrombectomy Improves Functional Outcomes in People with Large Vessel Occlusionhttps://practicalneurology.com/news/intra-arterial-tenecteplase-after-successful-thrombectomy-improves-functional-outcomes-in-people-with-large-vessel-occlusion/2475573/Adjunct intra-arterial TNKase (tenecteplase; Genentech, South San Francisco, CA) was associated with significant improvements in 90-day functional outcomes in individuals with acute ischemic stroke due to large vessel occlusion (LVO) presenting 4.5 to 24 hours prior to randomization who had alrea